Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-061150

Options or other derivatives

  • Director acquired 38,106 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ADAMS THOMAS PHD Director 2017-10-04 Grant or award · Stock Options +38,106 412,955 D: show line 1 in the form
Loading xslF345X03/a4.xml…